Ousted BARDA director pushed back on chloroquine claims and faced whistleblower retaliation, complaint says
After his surprise removal from the Department of Health and Human Services’ (HHS’) Biomedical Advanced Research and Development Authority (BARDA)—a key agency partnered with pharma companies on COVID-19 drugs, vaccines and diagnostics—former Director Rick Bright is alleging whistleblower retaliation by HHS leadership. In an 89-page complaint published by The New York Times, Bright says he was “involuntarily… Read More »